Carfilzomib-d8

Cat. No.: IBDI-434862

Carfilzomib-d8 is deuterium labeled Carfilzomib. Carfilzomib (PR-171) is an irreversible proteasome inhibitor with an IC50 of 5 nM in ANBL-6 and RPMI 8226 cells.

Product Details

Target	Proteasome | Autophagy | Apoptosis
Molecular Weight	727.96
SMILES	O=C([[email protected]@H](NC([[email protected]](CC1=CC=CC=C1)NC([[email protected]](CC(C)C)NC([[email protected]@H](NC(CN2C([2H])(C([2H])(OC([2H])(C2([2H])[2H])[2H])[2H])[2H])=O)CCC3=CC=CC=C3)=O)=O)=O)CC(C)C)[[email protected]@]4(OC4)C

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.